The mean total daily insulin dose was 54 ± 26 U, and the mean total bolus insulin dose was 21 ± 10 U. During the study period, there were no SARS-CoV-2 infections or overt COVID-19 cases among study participants. This evidence concerns the gene INS and COVID-19.